AMMECR1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.103400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.715600E-01
Normal-vs-Stage2
8.609200E-01
Normal-vs-Stage3
3.261000E-01
Normal-vs-Stage4
1.034790E-01
Stage1-vs-Stage2
7.821800E-01
Stage1-vs-Stage3
2.324600E-01
Stage1-vs-Stage4
3.346400E-02
Stage2-vs-Stage3
1.600040E-01
Stage2-vs-Stage4
1.429970E-02
Stage3-vs-Stage4
3.817600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.981200E-01
Normal-vs-AfricanAmerican
6.004400E-01
Normal-vs-Asian
4.825400E-01
Caucasian-vs-AfricanAmerican
5.066800E-01
Caucasian-vs-Asian
1.194850E-01
AfricanAmerican-vs-Asian
1.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.214000E-01
Normal-vs-Female
9.003000E-01
Male-vs-Female
9.628000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.997400E-01
Normal-vs-Age(41-60Yrs)
4.662000E-01
Normal-vs-Age(61-80Yrs)
8.771000E-01
Normal-vs-Age(81-100Yrs)
5.590000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.510400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.814400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.093600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.084000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.710100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.613400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.185400E-01
Normal-vs-Daily Drinker
7.150600E-01
Normal-vs-Weekly Drinker
2.549000E-01
Normal-vs-Occasional Drinker
5.857800E-01
Normal-vs-Social Drinker
9.400000E-01
Non Drinker-vs-Daily Drinker
9.763800E-01
Non Drinker-vs-Weekly Drinker
8.911700E-02
Non Drinker-vs-Occasional Drinker
8.961700E-02
Non Drinker-vs-Social Drinker
4.071800E-01
Daily Drinker-vs-Weekly Drinker
1.080820E-01
Daily Drinker-vs-Occasional Drinker
1.044150E-01
Daily Drinker-vs-Social Drinker
4.162600E-01
Weekly Drinker-vs-Occasional Drinker
7.834200E-01
Weekly Drinker-vs-Social Drinker
3.527000E-01
Occasional Drinker-vs-Social Drinker
4.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.508200E-01
Normal-vs-Grade 2
6.802200E-01
Normal-vs-Grade 3
6.663600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.700400E-03
Grade 1-vs-Grade 3
6.142700E-03
Grade 1-vs-Grade 4
8.508200E-01
Grade 2-vs-Grade 3
7.272400E-01
Grade 2-vs-Grade 4
6.802200E-01
Grade 3-vs-Grade 4
6.663600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.935200E-01
Normal-vs-NonDiabetic
9.413800E-01
Diabetic-vs-NonDiabetic
4.988200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.965400E-01
Normal-vs-NoPancreatitis
9.907800E-01
Pancreatitis-vs-NoPancreatitis
8.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.176800E-01
Normal-vs-N1
7.988000E-01
N0-vs-N1
2.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.378580E-01
Normal-vs-TP53-NonMutant
2.084000E-01
TP53-Mutant-vs-TP53-NonMutant
8.342600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
